Diagnostic Assay Development
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract with the Department of Energy, managed by Triad, focuses on the development of diagnostic tools utilizing lipid biomarker exploration for prime contractors licensing Bacterial Lipid Nanodiscs technology. The project involves designing assays to detect bacterial lipid biomarkers through the use of ELISA readers, fluorescence microscopy, and microfluidics, with the ultimate goal of delivering prototype kits or validated diagnostic assays. The performance of this contract will take place in Los Alamos, New Mexico. To ensure regulatory compliance, the developer must adhere to the FDA 510(k) pathway and maintain CLIA certification. Interested parties must submit their responses by December 16, 2026.
General Info
Agency
NAICS
Place of Performance
Los Alamos, NM, 87545, USASet-Aside
Documents
This scope was carved out of S-191192.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Energy → Triad - DOE Contractor
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
